Lv1
80 积分 2024-03-24 加入
In vivo gene therapy with CAR-T cells
16天前
已关闭
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody
20天前
已完结
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
20天前
已完结
Programmable macromolecule delivery via engineered trogocytosis
1个月前
已完结
Single-day nonactivated IL-18-armed CAR T cells establish a durable, stemlike state with enhanced persistence
1个月前
已完结
Building safeguards for gene therapy in haemophilia
1个月前
已关闭
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination
1个月前
已完结
Phase 1 Study of KITE-222, an Autologous CLL-1–directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
2个月前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
2个月前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
2个月前
已完结
皖公网安备34019202002308
